EXOSOME DIAGNOSTICS, INC.

Profile

Company Names

EXOSOME DIAGNOSTICS, INC.
EXOSOME THERANOSTICS, INC.

Addresses

266 2ND AVENUE, WALTHAM, MA 02451

840 MEMORIAL DRIVE, SUITE 3, CAMBRIDGE, MA 02139

LASKER BIOMEDICAL RESEARCH BUILDING, 3960 BROADWAY, SUITE 540, NEW YORK, NY 10032

AUDUBON BUSINESS AND TECHNOLOGY CENTER, 3960 BROADWAY, SUITE 540, NEW YORK, NY 10032

Phone Numbers

617-588-0500
(617) 588-0500
646-339-3139

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2008

State Incorporated:

DELAWARE

Total Amount Raised:

$90,892,587.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2017-06-21 
$30,290,634.00 
$30,290,634.00 
$0.00 
Equity 
5
2015-08-31 
$15,530,538.00 
INDEFINITE 
INDEFINITE 
Equity 
4
2015-06-19 
$1,483,973.00 
$2,200,000.00 
$716,027.00 
Equity 
3
2014-03-03 
$27,092,442.00 
$39,999,985.00 
$12,907,543.00 
Equity 
2
2012-08-10 
$7,000,000.00 
$8,500,000.00 
$1,500,000.00 
Debt 
1
2010-04-28 
$9,495,000.00 
$22,495,000.00 
$13,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SARA 
 
BARRINGTON 
EXECUTIVE OFFICER
JOHN 
 
BOYCE 
EXECUTIVE OFFICER, DIRECTOR
JOSEPH 
 
BOYSTAK 
DIRECTOR
WAYNE 
 
COMPER 
EXECUTIVE OFFICER
KAPIL 
 
DHINGRA 
DIRECTOR
DHINGRA 
 
KAPIL 
DIRECTOR
JAMES 
 
MCCULLOUGH 
EXECUTIVE OFFICER, DIRECTOR
THOMAS 
 
MCLAIN 
EXECUTIVE OFFICER, DIRECTOR
DAVID 
 
OKRONGLY 
EXECUTIVE OFFICER
JOSEPH 
 
SLATTERY 
DIRECTOR
STEVEN 
 
SOIGNET 
DIRECTOR
GREG 
 
ZDECHLIK 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-06-21 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-31 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-03 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-08-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK PARTNERS LLC
NONE
NONE
HUDSON CAPITAL ADVISORS BD LLC
NONE
NONE
HUDSON CAPITAL ADVISORS BD LLC